A reference tool used to provide clinicians with screening and treatment resources for substance use disorder within active duty and veteran populations, including resources on brief interventions and pharmacological treatment.
This document discusses the evidence for buprenorphine treatment of opioid dependent adolescents and young adults. It provides treatment recommendations, and highlights special issues that should be considered when treating this special population.
The Substance Abuse and Mental Health Services Administration (SAMHSA) provides this website so that physicians can improve the deliver and financing of prevention, treatment and recovery support services to patients.
Substance Abuse and Mental Health Services Administration (SAMHSA)
Development of this website was funded entirely by grant #R44DA12066 and contract #HHSN271200655304C from the National Institute on Drug Abuse (NIDA) at the National Institutes of Health. The website contents are solely the responsibility of the authors and do not necessarily represent the official views of NIDA. Ongoing development and maintenance is funded by the training fee and Clinical Tools, Inc. No commercial support is received.
Clinical Tools, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
Interactive training is delivered by the CTI Learning Ecosystem and our FAOS DLearning Drupal modules and requires IE 10/ higher, Firefox, Chrome or Safari.
Unless otherwise noted, individuals pictured are models and are used for illustrative purposes only.
developed & maintained by
A member of The Clinical Tools, Inc (CTI) Addiction Training Group: SBIRT Training | Opioid Risk Reduction | Buprenorphine Training
This site is for educational purposes only and medical decisions should not be based solely on its content. This site, its authors, and its consultants do not assume liability for errors or omissions.